ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Jensyn Acquistion Corp.

Jensyn Acquistion Corp. (JSYN)

5.025
0.00
(0.00%)
Closed July 04 3:00PM
0.00
0.00
(0.00%)
After Hours: -

Jensyn Acquistion Corp. (JSYN) Quote

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
5.025
( - )
Bid
5.05
Ask
5.80
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
5.025
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

JSYN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

JSYN - Frequently Asked Questions (FAQ)

What is the current Jensyn Acquistion Corp. share price?
The current share price of Jensyn Acquistion Corp. is US$ 5.025
What is the 1 year trading range for Jensyn Acquistion Corp. share price?
Jensyn Acquistion Corp. has traded in the range of US$ 0.00 to US$ 0.00 during the past year

JSYN Trades

More

Trades delayed

To get real-time trades, upgrade your account

Upgrade to Real-time

Discussion

View Full Feed
Twiggs333 Twiggs333 13 minutes ago
GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G
ATAI
Twiggs333 Twiggs333 13 minutes ago
GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G
CMPS
Twiggs333 Twiggs333 13 minutes ago
GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G
DFTX
Twiggs333 Twiggs333 14 minutes ago
GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G
ATAI CMPS DFTX
OMOLIVES OMOLIVES 18 minutes ago
Happy Fourth of July to all!...and a big thank you to the French. Vive la France!:

https://x.com/Phoenix2A_1980s/status/2073453266428387385
4u2nv2 4u2nv2 19 minutes ago
Every filing from the time Paul and Ben took over said there were 3 preferred shareholders. The third one was never named. Now, it's interesting to question how Newby got controlling interest when we do not know all of the facts concerning what Ben really wanted to accomplish with taking on the comm
MCIC
Eli's Gone Eli's Gone 31 minutes ago
I'm in: 11-5-24-19
Eli's Gone Eli's Gone 32 minutes ago
GL...
gfp927z gfp927z 32 minutes ago
>>> Look At Who Joined Open USD To Understand Where Money Is Going


Forbes

by Zennon Kapron

Jul 02, 2026


https://www.forbes.com/sites/digital-assets/2026/07/02/look-at-who-joined-open-usd-to-understand-where-money-is-going/
Sammy boy Sammy boy 38 minutes ago
Said it 4 months ago Bessent is the problem ! There is a reason he cold-cocked Tommy Boy.
FMCC
misterfishman misterfishman 50 minutes ago
Me too my side hobbies are researching new forms of energy from the enviroment,been at this for more than 20 yrs now and have accumilated a great deal oh knowledge.
NNRX
Atlanta1 Atlanta1 53 minutes ago
Joey - Why do you waste time on this lunatic?
SINT
FeMike FeMike 59 minutes ago
The original randomised primary endpoint (PFS) was negative and showed harm,

The simple fact that you don’t understand pseudo progression is more than enough to establish as also fact that you have no idea what you’re talking about.
NWBO
1jas 1jas 1 hour ago
If you go to otcmarkets for AFFU news dated August 22 2023 it does mention AFFU and Dell partnership.
AFFU
nyt nyt 1 hour ago
3 yrs down 79%. 5 yrs down 57%. 10 yrs down over 80%
VPLM
gemstone57 gemstone57 1 hour ago
Happy Fourth of July guys we live in the greatest Nation on earth.
MVNT
Tadaaa Tadaaa 1 hour ago
Sweeeet !!!
HBARUSD
johnydollar johnydollar 1 hour ago
Have you ever wondered why clown fish like to hang out around the sea anemones........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆
DBMM
GoodGuyBill GoodGuyBill 1 hour ago
Exactly 💯
NWBO
rcbindustry rcbindustry 2 hours ago
I'm staying on the sidelines for now. Rocket Companies has potential over the long term, but I think the stock will continue to depend heavily on interest rates and the housing market. I'll be watching the next few quarters before becoming more optimistic.
RKT
Genz2 Genz2 2 hours ago
Now who would have thought of what Steven K Sprague came up with on X recently??? This country, Microsoft, Intel and Wave need Steven’s thinking!!!! If Steven’s court case is still in abeyance that is a real travesty!!! Steven is VERY UNIQUE in how he can masterfully come up with solutions that a
johnydollar johnydollar 2 hours ago
You mean naked short enrichment right...........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 Ƕ
DBMM
Roman516 Roman516 2 hours ago
Happy 4th of July to all, GoodGuyBill, yes, I agree with you and your comment that "$35 billion is far too low for a treatment that will treat all tumor-based cancers (and we are not even discussing DIRECT, the combo patent, etc)."

If in fact, DCVax-D is able to address the majority o
NWBO
JusDePomme JusDePomme 2 hours ago
I feel stress Canada lost today truenortth!!
BIEI
Twiggs333 Twiggs333 2 hours ago
Curious to see how the next 6-12 months go.
CMPS